Microbot Medical Inc.
Microbot Medical Inc.（MBOT）股东结构
基于 13F 申报与流通股数据，展示机构、内部人与公众持股结构；下方为前十大机构、机构动向与内部人交易。
SEC 13F · FMP · MBOT · 截至 2025年9月30日
股东结构概览
74
机构持有人数
▲ 21 vs Q2
$31.79M
机构持仓总市值
▲ $20.74M vs Q2
45.57M
总流通股
freeFloat 99.95%
10.42M
13F 申报持股数
▲ 6.03M vs Q2
机构持仓% = 13F 持股数 ÷ 总流通股。内部人% = 100 − 自由流通率。散户% = 自由流通率 − 机构%。数据来源：FMP /symbol-positions-summary + /shares-float + SEC EDGAR。
前10大机构持仓
MBOT 最大股东 · 机构持仓
Q3 2025 · SEC 13F
显示前 10 家
| 机构 | 持股数 | 占比 | 权重 | 市值 | 申报日 | 变动 |
|---|---|---|---|---|---|---|
VANGUARD GROUP INC biological products, (no diagnostic substances) | 2.34M | 6.42% | 6.42% | $7.15B | Nov 7, 2025 | ▲ 292.9K |
CIBC PRIVATE WEALTH GROUP, LLC biological products, (no diagnostic substances) | 1.45M | 3.98% | 3.98% | $4.43B | Nov 24, 2025 | ▲ 842.0K |
biological products, (no diagnostic substances) | 1.45M | 3.98% | 3.98% | $4.43B | Nov 12, 2025 | NEW |
SUSQUEHANNA INTERNATIONAL GROUP, LLP biological products, (no diagnostic substances) | 1.25M | 3.43% | 3.43% | $3.81B | Nov 14, 2025 | ▲ 1.22M |
HEIGHTS CAPITAL MANAGEMENT, INC biological products, (no diagnostic substances) | 883.1K | 2.42% | 2.42% | $2.69B | Nov 18, 2025 | NEW |
GEODE CAPITAL MANAGEMENT, LLC biological products, (no diagnostic substances) | 493.4K | 1.35% | 1.35% | $1.51B | Nov 12, 2025 | ▲ 98.3K |
BLACKROCK, INC. biological products, (no diagnostic substances) | 490.2K | 1.34% | 1.34% | $1.50B | Nov 12, 2025 | ▲ 169.0K |
SUSQUEHANNA INTERNATIONAL GROUP, LLP biological products, (no diagnostic substances) | 293.3K | 80.38% | 80.38% | $894.57M | Nov 14, 2025 | ▲ 263.3K |
DNB ASSET MANAGEMENT AS biological products, (no diagnostic substances) | 243.6K | 66.77% | 66.77% | $743.07M | Nov 12, 2025 | ▲ 50.8K |
CITADEL ADVISORS LLC biological products, (no diagnostic substances) | 242.7K | 66.51% | 66.51% | $740.24M | Nov 14, 2025 | ▲ 154.1K |
数据来源：SEC 13F 申报文件。变动标识：isNew / isSoldOut / changeInSharesNumber。
机构仓位变动
Q3 2025 对比上季度
Q3 2025
26
增持
+3.89M 股18
新建仓
首次建仓3
减持
−289.5K 股0
清仓
完全退出净股数变化（前50家）
+3.60M
+3.89M / −289.5K
净新增持仓人
+41
新建 18 个 / 退出 0 个
基于前50家最大机构持仓统计，全市场实际数量可能不同。
内幕交易买卖情绪
MBOT 内幕交易记录
数据来源：SEC Form 4
6
买入笔数
0
卖出笔数
0.00
买卖比
$0M
卖出总金额
最近内幕交易记录
最近10条 · 仅普通股
| 姓名 · 职位 | 日期 | 类型 | 股数 | 价格 | 金额 | 交易后持股 | 申报 |
|---|---|---|---|---|---|---|---|
Stockburger Aileen Ptucha director | Apr 1, 2026 | Award | 10,000 | $2.37 | $23.7K | 10.0K | Form 4 ↗ |
Madden Martin J. director | Apr 1, 2026 | Award | 10,000 | $2.37 | $23.7K | 10.0K | Form 4 ↗ |
Wenderow Tal Baruch director | Apr 1, 2026 | Award | 10,000 | $2.37 | $23.7K | 10.0K | Form 4 ↗ |
Wilson David James director | Apr 1, 2026 | Award | 10,000 | $2.37 | $23.7K | 10.0K | Form 4 ↗ |
Burell Scott R director | Apr 1, 2026 | Award | 10,000 | $2.37 | $23.7K | 10.0K | Form 4 ↗ |
Laxminarain Prattipati director | Apr 1, 2026 | Award | 10,000 | $2.37 | $23.7K | 10.0K | Form 4 ↗ |
Gadot Harel Chairman, President and CEO | Feb 18, 2026 | Award | 480,000 | $2.10 | $1.01M | 480.0K | Form 4 ↗ |
Diaz-Cartelle Juan Chief Medical Officer | Feb 18, 2026 | Award | 105,000 | $2.10 | $220.5K | 105.0K | Form 4 ↗ |
Sharon Simon General Manager, CTO | Feb 18, 2026 | Award | 105,000 | $2.10 | $220.5K | 105.0K | Form 4 ↗ |
Vaknin Rachel Chief Financial Officer | Feb 18, 2026 | Award | 105,000 | $2.10 | $220.5K | 105.0K | Form 4 ↗ |
数据来源：SEC Form 4。买卖方向：acquisitionOrDisposition A=买入，D=卖出。已排除 RSU 归属（M-Exempt）。
关于机构与内部人持股结构
Microbot Medical Inc.（MBOT）主要由机构投资者持有，机构持股比例约为 22.9%。公司内部人员持股约 0.05%，散户及公众持股约占剩余的 77.08%。
Microbot Medical Inc. 最大机构股东为 VANGUARD GROUP INC，截至 September 30, 2025 持有约 2.34 million 股，占总流通股的 6.42%。
目前共有 74 家机构持有 MBOT 股票，合计持仓市值约 $31,792,781，数据来源为最新 SEC 13F 申报。
常见问题
MBOT ownershipMicrobot Medical Inc.（MBOT）主要由机构投资者持有，机构持股约 22.9%。最大股东为 VANGUARD GROUP INC，持股比例 6.42%。内部人员持股约 0.05%。数据来源 SEC Form 13F，截至 September 30, 2025。